Soft Tissue Sarcoma, Version 2.2022

被引：207

作者：

von Mehren, Margaret ^{[1
]}

Kane, John M., III ^{[2
]}

Agulnik, Mark ^{[3
]}

Bui, Marilyn M. ^{[4
]}

Carr-Ascher, Janai ^{[5
]}

Choy, Edwin ^{[6
]}

Connelly, Mary ^{[7
]}

Dry, Sarah ^{[8
]}

Ganjoo, Kristen N. ^{[9
]}

Gonzalez, Ricardo J. ^{[4
]}

Holder, Ashley ^{[10
]}

Homsi, Jade ^{[11
]}

Keedy, Vicki ^{[12
]}

Kelly, Ciara M. ^{[13
]}

Kim, Edward ^{[14
]}

Liebner, David

McCarter, Martin ^{[15
]}

V. McGarry, Sean ^{[16
]}

Mesko, Nathan W. ^{[17
,18
]}

Meyer, Christian ^{[19
]}

Pappo, Alberto S. ^{[20
]}

Parkes, Amanda M. ^{[21
]}

Petersen, Ivy A. ^{[22
]}

Pollack, Seth M. ^{[23
]}

Poppe, Matthew ^{[24
]}

Riedel, Richard F. ^{[25
]}

Schuetze, Scott ^{[26
]}

Shabason, Jacob ^{[27
]}

Sicklick, Jason K. ^{[28
]}

Spraker, Matthew B. ^{[29
,30
]}

Zimel, Melissa ^{[31
]}

Hang, Lisa E. ^{[32
]}

Sundar, Hema ^{[32
]}

Bergman, Mary Anne ^{[32
]}

机构：

[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[2] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[3] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[5] UC Davis Comprehens Canc Ctr, Sacramento, CA USA

[6] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[7] Ohio State Univ, Comprehens Canc Ctr, James Canc Hosp & Solove Res Inst, Columbus, OH 43210 USA

[8] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA

[9] Stanford Canc Inst, Stanford, CA USA

[10] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[11] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[12] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[13] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[14] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA USA

[15] Univ Colorado, Canc Ctr, Boulder, CO 80309 USA

[16] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[17] Univ Hosp, Case Comprehens Canc Ctr, Seidman Canc Ctr, Coimbatore, Tamil Nadu, India

[18] Cleveland Clin Taussig Canc Inst, Cleveland, OH USA

[19] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[20] Univ Tennessee, Hlth Sci Ctr, St Jude Res Hosp, Knoxville, TN 37996 USA

[21] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[22] Mayo Clin, Canc Ctr, Rochester, MN USA

[23] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[24] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[25] Duke Canc Inst, Durham, NC USA

[26] Univ Michigan, Roger Canc Ctr, Ann Arbor, MI 48109 USA

[27] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[28] UC San Diego Moores Canc Ctr, San Diego, CA USA

[29] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[30] Univ Washington, Sch Med, Seattle, WA 98195 USA

[31] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[32] Natl Comprehens Canc Network, Durham, NC USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2022年 / 20卷 / 07期

关键词：

RANDOMIZED PHASE-II; PREOPERATIVE RADIATION-THERAPY; DOXORUBICIN PLUS IFOSFAMIDE; ELECTRON-BEAM RADIOTHERAPY; HIGH-RISK EXTREMITY; NEOADJUVANT CHEMOTHERAPY; EUROPEAN-ORGANIZATION; RETROPERITONEAL SARCOMA; ADJUVANT CHEMOTHERAPY; 1ST-LINE TREATMENT;

D O I：

10.6004/jnccn.2022.0035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic char-acteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluation and treatment of pa-tients with STS requires a multidisciplinary team with demonstrated expertise in the management of these tumors. The complete NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Soft Tissue Sarcoma provide recommendations for the diagnosis, eval-uation, and treatment of extremity/superficial trunk/head and neck STS, as well as retroperitoneal/intra-abdominal STS, desmoid tumors, and rhabdomyosarcoma. This portion of the NCCN Guide-lines discusses general principles for the diagnosis and treatment of retroperitoneal/intra-abdominal STS, outlines treatment recom-mendations, and reviews the evidence to support the guidelines recommendations. J Natl Compr Canc Netw 2022;20(7):815???833 doi: 10.6004/jnccn.2022.0035

引用

页码：815 / 833

页数：19

共 139 条

[1] An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma [J].

Agulnik, Mark ;

Schulte, Brian ;

Robinson, Steven ;

Hirbe, Angela C. ;

Kozak, Kevin ;

Chawla, Sant P. ;

Attia, Steven ;

Rademaker, Alfred ;

Zhang, Hui ;

Abbinanti, Susan ;

Cehic, Rasima ;

Monga, Varun ;

Milhem, Mohammed ;

Okuno, Scott ;

Van Tine, Brian A. .

EUROPEAN JOURNAL OF CANCER, 2021, 154 :201-208

[2] External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis [J].

Albertsmeier, Markus ;

Rauch, Alexandra ;

Roeder, Falk ;

Hasenhuetl, Sandro ;

Pratschke, Sebastian ;

Kirschneck, Michaela ;

Gronchi, Alessandro ;

Jebsen, Nina L. ;

Cassier, Philippe A. ;

Sargos, Paul ;

Belka, Claus ;

Lindner, Lars H. ;

Werner, Jens ;

Angele, Martin K. .

ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (03) :754-767

[3] High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas [J].

Alektiar, KM ;

Hu, K ;

Anderson, L ;

Brennan, MF ;

Harrison, LB .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (01) :157-163

[4]

American Cancer Society, RISK FACT SOFT TISS

[5] The Role of Surgical Margin Status in Retroperitoneal Sarcoma [J].

Anaya, Daniel A. ;

Lev, Dina C. ;

Pollock, Raphael E. .

JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (08) :607-610

[6]

Anderson Sibyl E., 2006, Sarcoma, V2006, P1, DOI 10.1155/SRCM/2006/15947

[7]

[Anonymous], 2011, Cancer management: a multidisciplinary approach medical, surgical radiation oncology

[8]

[Anonymous], 2003, Cochrane Database Syst Rev, DOI DOI 10.1002/14651858.CD003293

[9] AN INTERGROUP PHASE-III RANDOMIZED STUDY OF DOXORUBICIN AND DACARBAZINE WITH OR WITHOUT IFOSFAMIDE AND MESNA IN ADVANCED SOFT-TISSUE AND BONE SARCOMAS [J].

ANTMAN, K ;

CROWLEY, J ;

BALCERZAK, SP ;

RIVKIN, SE ;

WEISS, GR ;

ELIAS, A ;

NATALE, RB ;

COOPER, RM ;

BARLOGIE, B ;

TRUMP, DL ;

DOROSHOW, JH ;

AISNER, J ;

PUGH, RP ;

WEISS, RB ;

COOPER, BA ;

CLAMOND, GH ;

BAKER, LH .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1276-1285

[10]

ANTMAN KH, 1990, SEMIN ONCOL, V17, P7

← 1 2 3 4 5 6 7 8 9 10 →